Febuxostat Powder Drug Treat Chronic Gout and Hyperuricemia

» Pharmaceutique » Les médicaments anti-inflammatoires » Febuxostat Powder Drug Treat Chronic Gout and Hyperuricemia

  • Caractéristiques

Buy Febuxostat Powder Drug Treat Chronic Gout and Hyperuricemia Online

 

Febuxostat Specification

Nom du produit: Febuxostat
NO CAS: 144060-53-7
Natural/Synthetic: Synthetic
Extraction source: A crystal form
Niveau: Pharmaceutical grade
Content: 99%
Apparence: poudre blanche
Emballage: 1KG/aluminum foil bag
Ingredients: 2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid
Physical and chemical properties: white or almost white powder; no smell, no taste. This product is dissolved in acetonitrile, acetone, methanol
Catégorie: Matières premières pharmaceutiques
Industrie: Médicaments
Champ: Anti gout drugs
produits reportés: febuxostat tablets, capsules
Application: Chronic hyperuricemia for the treatment of gout
Utilisation et dosage: once a day, 80mg once, and take it with food. After 2 à 4 weeks of treatment, if the serum uric acid value is higher than 6 mg/dL (357 μmol/L), increase the dose to 120 mg / jour.

 

Febuxostat Certificate of Analysis

Nom du produit Febuxostat
CAS No. 144060-53-7 Emballage externe Foil bag
Date de production 2018.2.10 Durée de conservation 2020.2.9
Norme adoptée Standard de l’entreprise
Éléments d’analyse Spécification du Résultats
Apparence White to almost white crystalline powder, inodore poudre cristalline blanche, inodore
Solubility Easily soluble in N,N-Dimethylformamide, soluble in Dimethyl sulfoxide. Sparingly soluble in Chloroform.Sligt soluble in methanol, practically insoluble in water Conformes
m.p. 207℃~211℃ 207.5℃~208.5℃
Identification Conformes Conformes
ImpurityⅠ NMT0.1% N.D.
ImpurityⅡ NMT0.1% N.D.
ImpurityⅢ NMT0.1% N.D.
ImpurityⅣ NMT0.1% 0.02%
Water ≤2.0% 0.5%
Résidu de calcination ≤0.1% 0.02%
Métaux lourds ≤20ppm Conformes
Ethanol ≤5000ppm 23ppm
Tetrahydrofuran ≤720ppm N.D.
N-hexane ≤290ppm N.D.
N,N-Dimethylformamide ≤880ppm N.D.
Dichloromethane ≤600ppm 24ppm
Essai 98.0%~102.0%(Calculated as anhydrous basis) 99.2%
Solubility Easily soluble in N,N-Dimethylformamide, soluble in Dimethyl sulfoxide. Sparingly soluble in Chloroform.Sligt soluble in methanol, practically insoluble in water Conformes
m.p. 207℃~211℃ 207.5℃~208.5℃
Identification Conformes Conformes
ImpurityⅠ NMT0.1% N.D.
ImpurityⅡ NMT0.1% N.D.
ImpurityⅢ NMT0.1% N.D.
ImpurityⅣ NMT0.1% 0.02%
Water ≤2.0% 0.5%
Résidu de calcination ≤0.1% 0.02%
Métaux lourds ≤20ppm Conformes
Ethanol ≤5000ppm 23ppm
Tetrahydrofuran ≤720ppm N.D.
N-hexane ≤290ppm N.D.
N,N-Dimethylformamide ≤880ppm N.D.
Dichloromethane ≤600ppm 24ppm
Essai 98.0%~102.0%(Calculated as anhydrous basis) 99.2%
Conclusion Qualifié

 

Febuxostat Common Side effects

The adverse effects associated with febuxostat therapy include nausea, diarrhea, arthralgia, headache, increased hepatic serum enzyme levels and rash.

 

Sales Contacts

Tel/Whatsapp: +86 17707567122
Wickr: mollyying
Télégramme: +86 185785209851
Skype: ying_2073
Mail: ying@wumeitech.com

formulaire ( nous reviendrons dès que possible )

prénom:
*
Email:
*
Message:

Vérification:
5 + 4 = ?

Peut-être que vous aimez aussi

  • catégories de produits

  • Messages récents

  • Partager